Jianerkang Medical Co.,Ltd. (SHA:603205)

Jianerkang Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	269.51	764.91	721.81	226.24	178.25	97.8
Cash & Short-Term Investments	799.38	764.91	721.81	226.24	178.25	97.8
Cash Growth	2.68%	5.97%	219.05%	26.92%	82.27%	3.28%
Accounts Receivable	207.32	255.99	212.32	235.5	189.16	138.75
Other Receivables	12.38	11.99	14.4	9.04	4.43	6.96
Receivables	219.7	267.98	226.72	244.54	193.59	145.71
Inventory	201.6	167.02	176.3	158.41	170.44	158.62
Prepaid Expenses	0.17	0.25	-	0.52	9.01	0.09
Other Current Assets	10.09	9.44	10.32	11.07	20.71	8.39
Total Current Assets	1,231	1,210	1,135	640.78	572.01	410.6
Property, Plant & Equipment	419.39	380.05	365.42	383.67	356.1	326.67
Other Intangible Assets	56.49	57.32	58.41	59.92	61.39	63.19
Long-Term Deferred Tax Assets	24.74	25.93	23.02	23.12	25.96	24.37
Long-Term Deferred Charges	32.79	33.04	6.6	3.02	2.09	2.07
Other Long-Term Assets	5.31	4.67	1.97	3.06	10.93	13.52
Total Assets	1,770	1,711	1,591	1,114	1,028	840.43

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	96.96	96.38	87.33	103.14	95.25	73.14
Accrued Expenses	28.94	37.12	27.7	34.07	42.3	31.45
Short-Term Debt	-	-	-	-	30.04	50.05
Current Portion of Leases	4.32	5.23	-	-	-	-
Current Income Taxes Payable	0.52	5.37	3.44	7.78	4.77	1.43
Current Unearned Revenue	6.98	6.19	6.48	4.32	8.85	4.59
Other Current Liabilities	79.28	16.9	9.79	16.47	21.98	14.76
Total Current Liabilities	217	167.18	134.74	165.79	203.19	175.42
Long-Term Leases	13.86	16.54	-	-	-	-
Long-Term Unearned Revenue	29.39	31	34.64	38.24	41.8	47.76
Long-Term Deferred Tax Liabilities	1.52	1.45	1.06	0.19	0.19	0.2
Total Liabilities	261.77	216.16	170.43	204.22	245.18	223.39

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	156	156	120	90	90	90
Additional Paid-In Capital	683.75	680.37	710.69	350.13	347.62	338.7
Retained Earnings	670.22	658.76	589.44	469.22	345.68	188.34
Comprehensive Income & Other	-2.06	-0.67	-0	-	-	-
Shareholders' Equity	1,508	1,494	1,420	909.35	783.29	617.04
Total Liabilities & Equity	1,770	1,711	1,591	1,114	1,028	840.43

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	18.18	21.76	-	-	30.04	50.05
Net Cash (Debt)	781.2	743.15	721.81	226.24	148.21	47.75
Net Cash Growth	3.35%	2.96%	219.05%	52.65%	210.40%	89.99%
Net Cash Per Share	4.94	4.73	5.82	1.93	1.27	0.41
Filing Date Shares Outstanding	156	156	156	117	117	117
Total Common Shares Outstanding	156	156	156	117	117	117
Working Capital	1,014	1,042	1,000	474.99	368.82	235.18
Book Value Per Share	9.67	9.58	9.10	7.77	6.70	5.27
Tangible Book Value	1,451	1,437	1,362	849.43	721.91	553.85
Tangible Book Value Per Share	9.30	9.21	8.73	7.26	6.17	4.73
Buildings	295.87	295.88	295.48	294.63	241.34	233.68
Machinery	371	354.99	346.13	321.4	303.54	259.27
Construction In Progress	72.39	26.99	4.97	11.9	17.36	7.33

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 3, 2026

Data Sources Report a data error